DK1511741T3 - Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika - Google Patents

Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika

Info

Publication number
DK1511741T3
DK1511741T3 DK03747269.3T DK03747269T DK1511741T3 DK 1511741 T3 DK1511741 T3 DK 1511741T3 DK 03747269 T DK03747269 T DK 03747269T DK 1511741 T3 DK1511741 T3 DK 1511741T3
Authority
DK
Denmark
Prior art keywords
decahydroisoquinoline
analgesics
carboxylic acid
ester derivatives
derivatives
Prior art date
Application number
DK03747269.3T
Other languages
Danish (da)
English (en)
Inventor
Paul Leslie Ornstein
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1511741T3 publication Critical patent/DK1511741T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03747269.3T 2002-04-26 2003-04-14 Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika DK1511741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37612002P 2002-04-26 2002-04-26
PCT/US2003/010466 WO2003091243A1 (en) 2002-04-26 2003-04-14 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics

Publications (1)

Publication Number Publication Date
DK1511741T3 true DK1511741T3 (da) 2013-01-21

Family

ID=29270765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03747269.3T DK1511741T3 (da) 2002-04-26 2003-04-14 Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika

Country Status (18)

Country Link
US (1) US7247644B2 (https=)
EP (1) EP1511741B1 (https=)
JP (2) JP2005529892A (https=)
KR (1) KR100757787B1 (https=)
CN (1) CN100436446C (https=)
AU (1) AU2003226277B2 (https=)
BR (1) BR0308911A (https=)
CA (1) CA2480026C (https=)
DK (1) DK1511741T3 (https=)
EA (1) EA009526B1 (https=)
ES (1) ES2398225T3 (https=)
IL (1) IL164773A (https=)
MX (1) MXPA04009857A (https=)
NZ (1) NZ535245A (https=)
PT (1) PT1511741E (https=)
SI (1) SI1511741T1 (https=)
WO (1) WO2003091243A1 (https=)
ZA (1) ZA200409552B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100757787B1 (ko) * 2002-04-26 2007-09-11 일라이 릴리 앤드 캄파니 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
MX2022016223A (es) 2020-07-02 2023-02-23 Sea Pharmaceuticals Llc Composiciones farmaceuticas de acido 6-(2-(2h-tetrazol-5-il)etil)- 6-fluorodecahidroisoquinolina-3-carboxilico y derivados de ester del mismo.
WO2022261287A1 (en) * 2021-06-09 2022-12-15 Proniras Corporation Methods of treating nerve agent-induced seizures
WO2023130008A2 (en) * 2022-01-01 2023-07-06 Sea Pharmaceuticals Llc Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5356902A (en) 1992-11-06 1994-10-18 Eli Lilly And Company Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists
US5446051A (en) 1994-05-31 1995-08-29 Eli Lilly And Company Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
HUP0002030A3 (en) 1997-04-07 2002-01-28 Lilly Co Eli Use of glur5 receptorantagonists for the treatment of pain
EP1200073B1 (en) 1999-07-06 2007-01-10 Eli Lilly And Company SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
WO2001002367A2 (en) * 1999-07-06 2001-01-11 Eli Lilly And Company Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
AU2574801A (en) 1999-12-22 2001-07-03 Eli Lilly And Company Selective iGLUR5 receptor antagonists
WO2002053556A2 (en) 2001-01-05 2002-07-11 Eli Lilly And Company Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
WO2003024453A1 (en) 2001-01-05 2003-03-27 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU2002227020A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
WO2003024934A2 (en) 2001-01-05 2003-03-27 Eli Lilly And Company Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
WO2003082856A1 (en) 2002-03-22 2003-10-09 Eli Lilly And Company Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
KR100757787B1 (ko) * 2002-04-26 2007-09-11 일라이 릴리 앤드 캄파니 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체

Also Published As

Publication number Publication date
WO2003091243A8 (en) 2005-03-31
CN1649862A (zh) 2005-08-03
ZA200409552B (en) 2006-02-22
IL164773A (en) 2011-08-31
NZ535245A (en) 2007-11-30
PT1511741E (pt) 2013-02-05
JP2010235623A (ja) 2010-10-21
AU2003226277A1 (en) 2003-11-10
IL164773A0 (en) 2005-12-18
KR20040102171A (ko) 2004-12-03
EA009526B1 (ru) 2008-02-28
CA2480026A1 (en) 2003-11-06
SI1511741T1 (sl) 2013-02-28
CA2480026C (en) 2011-06-07
WO2003091243A1 (en) 2003-11-06
US7247644B2 (en) 2007-07-24
KR100757787B1 (ko) 2007-09-11
EP1511741B1 (en) 2012-12-26
MXPA04009857A (es) 2004-12-07
AU2003226277B2 (en) 2009-03-26
US20050256155A1 (en) 2005-11-17
EP1511741A1 (en) 2005-03-09
JP2005529892A (ja) 2005-10-06
CN100436446C (zh) 2008-11-26
BR0308911A (pt) 2005-01-04
ES2398225T3 (es) 2013-03-14
EA200401432A1 (ru) 2005-04-28

Similar Documents

Publication Publication Date Title
DK1488790T3 (da) Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
EP1674473A4 (en) Photoacid generator
NO20042592L (no) Indol-2-karboksamider som faktor XA inhibitorer
NO2014011I1 (no) Vortioksetin eller et farmasøytisk akseptabelt syreaddisjonssalt dera
DK1523493T3 (da) Nye tubulysinanaloge
NO20014412D0 (no) Forbindelser nyttige som anti-inflammatoriske midler
IS7818A (is) Tafin losun á amfetamínsöltum
NO20031797L (no) Heteroarylalkylpiperazin-derivater som fettsyreoksidasjonsinhibitorer
DK0983273T3 (da) Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler
PT2431604T (pt) Processo para controlar uma turbina eólica
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20044998L (no) Tioksantinderivater som myeloperoksidaseinhibitorer
NO20052921D0 (no) Fenylsubstituerte piperidinforbindelser for anvendelse som PPAR aktivatorer
IS6987A (is) Nýjar súlfónsýru afleiður
IS2421B (is) Nýir etónógestrel esterar
NO331228B1 (no) Anvendelse av en sammensetning som omfatter et ketotifensalt
DE60307258D1 (de) Tolterodin-salze
DK1536796T3 (da) N-arylpiperidinsubstituerede biphenylcarboxamider som inhibitorer af apolipoprotein B-sektion
NO20042990L (no) Pyrrolidin-2-oner som faktor XA inhibitorer
DK2112154T3 (da) Estre i position 20 af camptothecin
FI20022099L (fi) Tornikattila
DK1511741T3 (da) Esterderivater af en decahydroisoquinolin-3-carboxylsyre som analgetika
DK1513806T3 (da) Sulfonsyresalte af sulfonsyrederivater
DE10392970D2 (de) Lagerung einer Welle
ITMI20030063A1 (it) Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.